Biología Celular, Genética, Histología y Farmacología
Departamento
Institute Catalá Oncología
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Institute Catalá Oncología (2)
2010
-
BRCA1 5272-1G>A and BRCA2 5374delTATG are founder mutations of high relevance for genetic counselling in breast/ovarian cancer families of Spanish origin
Clinical Genetics, Vol. 77, Núm. 1, pp. 60-69
2007
-
Fas-activated serine/threonine phosphoprotein (FAST) is a regulator of alternative splicing
Proceedings of the National Academy of Sciences of the United States of America, Vol. 104, Núm. 27, pp. 11370-11375